Covered recipient · General Payments record
WILLIAM R MARON
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,965.75
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $348.44 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $74.22 | 4 |
| Harrow Eye, LLC | $65.62 | 3 |
| Bausch & Lomb Americas Inc. | $54.56 | 3 |
| Dompe US, Inc. | $49.46 | 2 |
| Oyster Point Pharma, Inc. | $43.45 | 2 |
| ABBVIE INC. | $37.69 | 2 |
| Thea Pharma Inc. | $23.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.90 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969441 | CMS |
| ABBVIE INC. | $16.79 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969443 | CMS |
| Amgen Inc. | $20.57 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115904282 | CMS |
| Amgen Inc. | $20.56 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115904288 | CMS |
| Amgen Inc. | $13.68 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115904294 | CMS |
| Amgen Inc. | $19.41 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115904299 | CMS |
| Bausch & Lomb Americas Inc. | $13.29 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140468205 | CMS |
| Bausch & Lomb Americas Inc. | $23.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140468201 | CMS |
| Bausch & Lomb Americas Inc. | $17.84 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140468203 | CMS |
| Dompe US, Inc. | $25.97 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151418459 | CMS |
| Dompe US, Inc. | $23.49 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151418461 | CMS |
| Harrow Eye, LLC | $21.89 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609062 | CMS |
| Harrow Eye, LLC | $26.54 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609064 | CMS |
| Harrow Eye, LLC | $17.19 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609066 | CMS |
| Oyster Point Pharma, Inc. | $18.84 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147405368 | CMS |
| Oyster Point Pharma, Inc. | $24.61 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147400948 | CMS |
| Thea Pharma Inc. | $23.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074542925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.